According to www.techsciresearch.com latest Report- Global glycobiology market is expected to grow at a formidable rate during the forecast period. The global glycobiology market is driven by the growing prevalence of chronic diseases such as cancer, diabetics, renal diseases, among others, which has increased the demand for personalized medicines Report URL- https://www.techsciresearch.com/report/glycobiology-market/4635.html

1. MARKET INTELLIGENCE . CONSULTING
www.techsciresearch.com
GLOBAL GLYCOBIOLOGY MARKET
FORECAST & OPPORTUNITIES
2015 – 2025

2. 2
Scope of Report
Product of Interest (POI): Glycobiology
Review Period
2015 – 2018
Base Year
2019
Estimated Year
2020
Forecast Period
2021 – 2025
Year Range
REGION
• North America
• Europe
• Middle East & Africa
• Asia-Pacific
• South America
Global glycobiology market is expected to grow at a formidable rate during the forecast period.
The global glycobiology market is driven by the growing prevalence of chronic diseases such
as cancer, diabetics, renal diseases, among others, which has increased the demand for
personalized medicines. This in turn has increased the drug discovery process around the
globe, which is anticipated to positively impact growth of market during the forecast period.
Also, increasing grants by different governments especially in the developing nations for R&D
activities is further expected to bolster the growth of market over the next few years.
Market Segmentation
TYPE OF KIT
• Glycan Releasing Kit
• Glycan Labelling Kit
• Glycan Purification Kit
• Others
TYPE OF ENZYME
• Glycosidases & Neuramidases
• Glycosyltransferases & Sialytransferases
• Carbohydrate Kinases
• Carbohydrate Sulfotransferases
• Protein Sulfotransferases
• Others
APPLICATION
• Drug Discovery
• Disease Diagnostics
• Virology
• Cell Biology
• Oncology
• Others
END USER
• Research Institutes
• Diagnostic Centers
• Hospitals
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies
• Others

3. 3
Table of Contents
S. No. Contents Page No.
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Glycobiology Market
4. Executive Summary
5. Voice of Customer
6. Global Glycobiology Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1.
By Type of Enzyme (Glycosidases & Neuramidases, Glycosyltransferases & Sialytransferases,
Carbohydrate Kinases, Carbohydrate Sulfotransferases, Protein Sulfotransferases, Others)
6.2.2. By Type of Kit (Glycan Releasing Kit, Glycan Labelling Kit, Glycan Purification Kit,
Others)
6.2.3. By Application (Drug Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology, Others)
6.2.4.
By End User (Research Institutes, Diagnostic Centers, Hospitals, Clinical Laboratories,
Pharmaceutical & Biotechnology Companies, Others)
6.2.5. By Company (2019)
6.2.6. By Region (Asia-Pacific, Europe, North America, South America and Middle East & Africa)
6.3. Product Market Map

4. 4
Table of Contents
S. No. Contents Page No.
7. Asia-Pacific Glycobiology Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type of Enzyme
7.2.2. By Type of Kit
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country (China, India, Australia, Japan, South Korea)
7.3. Asia-Pacific: Country Analysis
7.3.1. China Glycobiology Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type of Enzyme
7.3.1.2.2. By Type of Kit
7.3.1.2.3. By Application
7.3.1.2.4. By End User

5. 5
Table of Contents
S. No. Contents Page No.
7.3.2. India Glycobiology Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type of Enzyme
7.3.2.2.2. By Type of Kit
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. Australia Glycobiology Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type of Enzyme
7.3.3.2.2. By Type of Kit
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4. Japan Glycobiology Market Outlook

6. 6
Table of Contents
S. No. Contents Page No.
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type of Enzyme
7.3.4.2.2. By Type of Kit
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5. South Korea Glycobiology Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type of Enzyme
7.3.5.2.2. By Type of Kit
7.3.5.2.3. By Application
7.3.5.2.4. By End User
8. Europe Glycobiology Market Outlook

7. 7
Table of Contents
S. No. Contents Page No.
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type of Enzyme
8.2.2. By Type of Kit
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country (France, Germany, United Kingdom, Italy, Spain)
8.3. Europe: Country Analysis
8.3.1. France Glycobiology Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type of Enzyme
8.3.1.2.2. By Type of Kit
8.3.1.2.3. By Application
8.3.1.2.4. By End User

8. 8
Table of Contents
S. No. Contents Page No.
8.3.2. Germany Glycobiology Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type of Enzyme
8.3.2.2.2. By Type of Kit
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. United Kingdom Glycobiology Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type of Enzyme
8.3.3.2.2. By Type of Kit
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. Italy Glycobiology Market Outlook

9. 9
Table of Contents
S. No. Contents Page No.
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type of Enzyme
8.3.4.2.2. By Type of Kit
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Spain Glycobiology Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type of Enzyme
8.3.5.2.2. By Type of Kit
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9. North America Glycobiology Market Outlook
9.1. Market Size & Forecast

10. 10
Table of Contents
S. No. Contents Page No.
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type of Enzyme
9.2.2. By Type of Kit
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country (United States, Canada, Mexico)
9.3. North America: Country Analysis
9.3.1. United States Glycobiology Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type of Enzyme
9.3.1.2.2. By Type of Kit
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. Canada Glycobiology Market Outlook
9.3.2.1. Market Size & Forecast

11. 11
Table of Contents
S. No. Contents Page No.
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type of Enzyme
9.3.2.2.2. By Type of Kit
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. Mexico Glycobiology Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type of Enzyme
9.3.3.2.2. By Type of Kit
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10. South America Glycobiology Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type of Enzyme

12. 12
Table of Contents
S. No. Contents Page No.
10.2.2. By Type of Kit
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country (Brazil, Argentina, Colombia)
10.3. South America: Country Analysis
10.3.1. Brazil Glycobiology Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1 By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type of Enzyme
10.3.1.2.2. By Type of Kit
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Argentina Glycobiology Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1 By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type of Enzyme
10.3.2.2.2. By Type of Kit

13. 13
Table of Contents
S. No. Contents Page No.
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. Colombia Glycobiology Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1 By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type of Enzyme
10.3.2.2.2. By Type of Kit
10.3.2.2.3. By Application
10.3.2.2.4. By End User
11. Middle East & Africa Glycobiology Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Type of Enzyme
11.2.2. By Type of Kit
11.2.3. By Application
11.2.4. By End User

14. 14
Table of Contents
S. No. Contents Page No.
11.2.5. By Country (South Africa, Saudi Arabia, UAE)
11.3. Middle East & Africa : Country Analysis
11.3.1. South Africa Glycobiology Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Type of Enzyme
11.3.1.2.2. By Type of Kit
11.3.1.2.3. By Application
11.3.1.2.4. By End User
11.3.2. Saudi Arabia Glycobiology Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Type of Enzyme
11.3.2.2.2. By Type of Kit
11.3.2.2.3. By Application
11.3.2.2.4. By End User
11.3.3. UAE Glycobiology Market Outlook
11.3.3.1. Market Size & Forecast

15. 15
Table of Contents
S. No. Contents Page No.
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Type of Enzyme
11.3.3.2.2. By Type of Kit
11.3.3.2.3. By Application
11.3.3.2.4. By End User
11.3.4. Kuwait Glycobiology Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Type of Enzyme
11.3.4.2.2. By Type of Kit
11.3.4.2.3. By Application
11.3.4.2.4. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Competition Outlook

16. 16
Table of Contents
S. No. Contents Page No.
14.2. Company Profiles
15. Strategic Recommendations
16. About Us & Disclaimer

17. RESEARCH
METHODOLOGY

18. 18
Research Methodology
 Identifying Key Opinion
Leaders
 Questionnaire Design
 In-depth Interviews
Data
Collection
Developing List
of Respondents
Formulating
Questionnaire
Market
Profiling
Data
Validation
Data
Analysis
In-depth secondary
research was conducted to
determine top players in
the global glycobiology
market, overall market size
and segmental market size.
In order to conduct
industry experts’
interviews, TechSci
formulated a detailed
discussion guide.
List of industry
players and industry
specialists was
developed.
TechSci conducted
interviews with
industry experts and
industry players for
data collection and
verification.
Data obtained as a
result of primary
and secondary
research was
validated through
rigorous
triangulation.
The data was scrutinized
using MS-Excel, statistical
tools and internal
proprietary database to
obtain qualitative and
quantitative insights about
the global glycobiology
market.
Data
Collection
Data Filter
& Analysis
Research &
Intelligence
Actionable
Insights
Business
Solution
Primary Research Desk Research Company Analysis
 Recent Developments
 Market Changing
Aspects/Dynamics
 Government Policies
 Conclusion
 Market Participants
 Key Strengths
 LinkedIn
 TechSci Internal
Database
 Factiva
 Hoovers
Paid Sources
 Company Websites
 Company Annual
Reports
 White Paper Study
 Financial Reports
 Investor
Presentations
 Regulatory Body
 Associations, etc.
Secondary
Research
Primary Research

19. 19
Research Methodology
Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of the global glycobiology market. The team has
market, while considering the major influencing factors such as growing prevalence of chronic diseases such as cancer, diabetics, renal
process around the globe, among others. The study includes market forecasting, which would enable our clients to take better decisions
sustainability in the global glycobiology market.
Methodology Followed for Calculation of Market Size:
• Market Size by Value: Market size, in terms of value, for the year 2019 was calculated based on information collected through
exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as companies, suppliers,
industry experts, and other industry participants.
• The team interviewed more than 15 – 20 companies, 100 – 120 End User, 15 – 20 industry experts and other value chain
overall market size from 2015 to 2019, which was validated by the Delphi technique. Taking standard deviation into consideration,
market size data during 2015-2019.

20. 20
Research Methodology
• Respondents were asked about the current and future market growth rates, market shares by type of enzyme, by type of kit, by application, by end user, by each region, and by
company. Removing the outlier responses, the geometric mean of growth estimates and provider wise revenue shares generated across various segments were considered, to
arrive at the final revenue shares. Revenue shares generated across various segments were further triangulated from other stakeholders.
Methodology Followed for Calculation of Market Shares:
• Market shares shares by type of enzyme, by type of kit, by application, by end user, by each region, and by company were calculated based on the responses received through
primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from various segments of glycobiology market. The final
shares were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers.
Methodology Followed for Forecasting:
• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software.
• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global glycobiology market, TechSci Research used
various forecast techniques such as:
 Moving Average
 Time Series Analysis
 Regression Analysis
 Econometric and Judgmental Analysis

21. 21
Research Methodology
TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during
short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market
including market share data. The currency used in the report is the United States Dollar (USD), with the market size indicated in USD million.
Partial List of Companies Interviewed Key Secondary Sources
 Merck & Co., Inc.
 Agilent Technologies, Inc.
 Thermo Fisher Scientific
 New England Biolabs, Inc.
 Shimadzu Corporation
 Takara Bio Inc.
 Waters Corporation
 Asparia Glycomics S.L.
 Bruker Corporation
 RayBiotech, Inc.
 Z Biotech, LLC.
 Chemily Glycoscience
 Dextra Laboratories Ltd.
 Lectenz Bio
 Ludger Ltd
 R&D Systems, Inc.
 Bio-Techne
 Danaher Corporation
 S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
 ProZyme
 World Bank
 TechSci Research Proprietary Database & Knowledge Repository
 Company Annual Reports
 Industry Magazines
 Industry Reports
 News Dailies
 Credible Paid Databases

22. 22
Industry Brief
According to TechSci Research report, “Global Glycobiology Market By Type of Enzyme (Glycosidases & Neuramidases, Glycosyltransferases & Sialytransferases, Carbohydrate kinases,
Carbohydrate Sulfotransferases, Protein Sulfotransferases, Others), By Type of Kit (Glycan Releasing Kit, Glycan Labelling Kit, Glycan Purification Kit, Others), By Application (Drug Discovery,
Disease Diagnostics, Virology, Cell Biology, Oncology, Others), By End User (Research Institutes, Diagnostic Centers, Hospitals, Clinical Laboratories, Pharmaceutical & biotechnology companies,
Others), By Region, Forecast & Opportunities, 2025”, the global glycobiology market is expected to grow at a formidable rate during the forecast period on account of the increasing R&D activities
related to glycomics and proteomics. Additionally, ongoing technological advancements especially in the instrumentations and kits used in glycobiology technique coupled with the novel product
launches by the major players operating in the market is further expected to propel the market during forecast period. Also, the use of glycobiology in the anti-cancer drug discovery is anticipated to
spur the growth of market over the next few years. Furthermore, the use of glycomics in the field of dermatology for studying the aging pattern of the skin is expected to positively impact the growth of
market through 2025. Also, synthesis, differentiation and proliferation of skin can be achieved using glycobiology thereby increasing its application in tissue architecture. However, high costs of the
instrumentation, tools or kits used in the technique make it expensive which can hamper the growth of market during forecast period. Additionally, stringent government policies also hinder the
market growth. Moreover, the technique requires skilled personnel to perform it and lack of such skilled people might impede the growth of market over the next few years.
The global glycobiology market is segmented based on type of enzyme, type of kit, application, end user, company and region. Based on the type of kit, the market can be categorized into glycan
releasing kit, glycan labelling kit, glycan purification kit and others. The glycan releasing kit segment is expected to dominate the market since these kits are applicable for different enzymes such as
glycosyltransferases, sialyltransferases, sulfotransferases, among others that generate leaving groups with a removable phosphate. Additionally, these kits are quantitative, convenient and amenable
to high throughput analysis. Based on application, the market can be fragmented into drug discovery, disease diagnostics, virology, cell biology, oncology and others. The drug discovery segment is
expected to dominate the market on account of the increasing demand for personalized medicines. Additionally, increasing R&D activities by the major players operating in the market and different
governments around the globe for the development of novel therapeutics is further anticipated to drive the growth of this segment during the next five years. Based on end user, the market can be
grouped into research institutes, diagnostic centers, hospitals, clinical laboratories, pharmaceutical & biotechnology companies and others. The pharmaceutical & biotechnology companies segment
is expected to register highest CAGR during the forecast period. This can be accredited to the growing demand for new drug discovery and development especially for treatment of chronic diseases
such as diabetes, cancer, among others.
Merck & Co., Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, New England Biolabs, Inc., Shimadzu Corporation, Takara Bio Inc., Waters Corporation, Asparia Glycomics S.L., Bruker
Corporation, RayBiotech, Inc., Z Biotech, LLC., Chemily Glycoscience, Dextra Laboratories Ltd., Lectenz Bio, Ludger Ltd, R&D Systems, Inc., Bio-Techne, Danaher Corporation, S-BIO (subsidiary of
Sumitomo Bakelite Co. Ltd., Japan), ProZyme and others are some of the leading players operating in global glycobiology market. The companies operating in the market are using organic strategies
such as product launches, mergers and collaborations to boost their share. For instance, in June 2019, Agilent Technologies (US) launched InfinityLab LC/MSD iQ System.

23. 23
Sample Data - Snapshot
Global Glycobiology Market Size, By Value (USD Million), 2015-2025F
5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00
2015 2019 2020E 2025F
By Value (USD Million)
CAGR By Value CAGR By Value
XX% YY%
North America Glycobiology Market Share, By Type of Enzyme, By Value, 2015–2025F
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
2015
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
Glycosidases & Neuramidases Glycosyltransferases & Sialytransferases
Carbohydrate Kinases Carbohydrate Sulfotransferases
Protein Sulfotransferases Others
United States Glycobiology Market Share, By Type of Kit, By Value, 2015–2025F
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
2015
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
Glycan Releasing Kit Glycan Labelling Kit Glycan Purification Kit Others

24. 24
Report Ordering
Report Name: GLOBAL GLYCOBIOLOGY MARKET
FORECAST & OPPORTUNITIES
2015 – 2025
To View Sample OR Purchase Report
License Type Price
Single User License $4450
Multi-User License $5450
Custom Research License $9450

25. About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in
number of areas to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality
analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and global
company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.
Related Reports
• Global Portable Ventilator Market, By Application (Invasive Ventilation, Non-Invasive Ventilation), By Mode (Pressure Mode Ventilation; Volume
Mode Ventilation; Combined Mode Ventilation), By Application (Aeromedical; Pediatrics; Domiciliary Ventilation; Non-Invasive Ventilation), By End
User (Hospital; Ambulance; Clinic; Rehabilitation Center; Others), By Region, Forecast & Opportunities, 2025
• Global Biomedical Refrigerators and Freezers Market, By Product (Pass-Through, Explosion Safe, Flammable storage, Combo/Dual Temperature,
Others), By Storage (Blood, Vaccines, Plasma, DNA, Flammable chemicals, Others), By Temperature (RNA & DNA, Vaccines), By Capacity (138L,
169L, 221L, 230L, 426L, 690L, Others), By End-user (Hospitals, Pharmacies, Diagnostic Centers, Research Laboratories, Blood Banks), By Region,
Forecast & Opportunities, 2025
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely,
accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it
considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible
for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the
subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this
document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior
approval of TechSci Research.
TechSci Research – North America
708 Third Avenue, Manhattan,
New York, United States
Tel: +1- 646- 360- 1656
Email: sales@techsciresearch.com
www.techsciresearch.com
Disclaimer
TechSci Research – Europe
54, Old brook, Bretton,
Peterborough,
United Kingdom
Email: sales@techsciresearch.com
www.techsciresearch.com
TechSci Research – Asia-Pacific
B – 44, Sector – 57, Noida, National Capital
Region, U.P. - India
Tel: +91-120-4523900
Email: sales@techsciresearch.com
www.techsciresearch.com